Showing results (1621-1630 of 3,792) with videos related to
Sort By:
Pageof 380
Oncoimmunology|September 22, 2017
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancerFenne L Komdeur, Thalina M Prins, Stephanie van de Wall, et al.Oncoimmunology|September 22, 2017
Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responsesReem Ghinnagow, Julie De Meester, Luis Javier Cruz, et al.Oncoimmunology|March 5, 2016
Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumorsMichele Ardolino, David H RauletOncoimmunology|March 5, 2016
Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cellsJonathan P H Fisher, Barry Flutter, Florian Wesemann, et al.Oncoimmunology|March 5, 2016
T cell receptor mimic antibodies for cancer therapyLeonid Dubrovsky, Tao Dao, Ron S Gejman, et al.Oncoimmunology|March 5, 2016
B7-H4 is a positive regulator of antitumor immunityRamtin Rahbar, Pamela S OhashiOncoimmunology|March 5, 2016
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastasesAnna S Berghoff, Elisabeth Fuchs, Gerda Ricken, et al.Oncoimmunology|March 5, 2016
Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30Christian Kellner, Andreas Günther, Andreas Humpe, et al.Oncoimmunology|March 5, 2016
Radiotherapy supports tumor-specific immunity by acute inflammationLaura Surace, Nicole Angelika Scheifinger, Anurag Gupta, et al.Oncoimmunology|March 5, 2016
Hyperthermic intra-peritoneal chemotherapy and anticancer immune responseBarbara Zunino, Jean-Ehrland RicciPageof 380